Tharimmune To Participate in Two Upcoming Investor Conferences in May [Yahoo! Finance]
Tharimmune To Participate in Two Upcoming Investor Conferences in May
Tharimmune Announces Option Agreement for Key Technologies for Generating HER2/HER3 Antibody Drug Conjugates (ADCs) [Yahoo! Finance]
Tharimmune Announces Option Agreement for Key Technologies for Generating HER2/HER3 Antibody Drug Conjugates (ADCs)
Tharimmune Announces Scientific Advisory Board to Drive Clinical-Stage Lead in Chronic Liver Disease and Early-Stage Tunable Knob Domains for Generating Antibody Drug Conjugate (ADC) Biotherapeutics [Yahoo! Finance]